<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0872-1904</journal-id>
<journal-title><![CDATA[Portugaliae Electrochimica Acta]]></journal-title>
<abbrev-journal-title><![CDATA[Port. Electrochim. Acta]]></abbrev-journal-title>
<issn>0872-1904</issn>
<publisher>
<publisher-name><![CDATA[Sociedade Portuguesa de Electroquímica]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0872-19042010000200002</article-id>
<title-group>
<article-title xml:lang="pt"><![CDATA[The Polarographic Reduction and Electrode Kinetics of Anti-depressant Drug Bupropion Hydrochloride]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Samota]]></surname>
<given-names><![CDATA[Sharda]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Garg]]></surname>
<given-names><![CDATA[Ashish]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pandey]]></surname>
<given-names><![CDATA[Rajayashree]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,University of Rajasthan Department of Chemistry ]]></institution>
<addr-line><![CDATA[Jaipur ]]></addr-line>
<country>India</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2010</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2010</year>
</pub-date>
<volume>28</volume>
<numero>2</numero>
<fpage>87</fpage>
<lpage>94</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_arttext&amp;pid=S0872-19042010000200002&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_abstract&amp;pid=S0872-19042010000200002&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_pdf&amp;pid=S0872-19042010000200002&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[The electroreduction of the antidepressant drug Bupropion hydrochloride has been studied in aqueous media at dme. Single well defined wave was obtained in different supporting electrolytes, like, KNO3, ammonium citrate buffer, acetate buffer, B. R. buffer, etc. The effect of pH on this reduction has been studied in B. R. buffer in the pH range 3.13 - 11.0. The Bupropion hydrochloride is best reduced in slightly acidic medium. This behavior was attributed to the reduction of >C=O group present in the drug. The effect of concentration and temperature on half wave potential has also been investigated. The reduction of drug was found to be irreversible and diffusion controlled, hence kinetic parameters (K0fh, &#945;n) are evaluated using Meites Israel and Gaur Bharagav,s method. Further, with increase in temperature the values of K0fh also increase, showing that irreversibility of the system decreases on increasing the temperature.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[DC polarography]]></kwd>
<kwd lng="en"><![CDATA[reduction]]></kwd>
<kwd lng="en"><![CDATA[antidepressant drug]]></kwd>
<kwd lng="en"><![CDATA[Bupropion hydrochloride]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[ <P ><B>The Polarographic Reduction and Electrode Kinetics of Anti-depressant Drug    Bupropion Hydrochloride</B></P>     <P >&nbsp;</P>     <P ><B  >Sharda Samota, Ashish Garg, Rajayashree Pandey<a href="#c1">*</a><a name="topc1"></a></B>    &nbsp;</P>     <P >&nbsp;</P>     <P >Department of Chemistry, University of Rajasthan, Jaipur, India</P>     <P >&nbsp;</P>     <P >DOI: 10.4152/pea.201002087</P>     <P >&nbsp;</P>     <P ><B  >Abstract</B></P>     <P >The  electroreduction of the antidepressant drug Bupropion hydrochloride has been  studied in aqueous media at dme. Single well defined wave was obtained in  different supporting electrolytes, like, KNO<SUB>3, </SUB>ammonium citrate  buffer, acetate buffer, B. R. buffer, etc. The effect of pH on this reduction  has been studied in B. R. buffer in the pH range 3.13 &#8211; 11.0. The Bupropion  hydrochloride is best reduced in slightly acidic medium. This behavior was  attributed to the reduction of &gt;C=O group present in the drug. The effect of  concentration and temperature on half wave potential has also been investigated.  The reduction of drug was found to be irreversible and diffusion controlled,  hence kinetic parameters (K<SUP>0</SUP><SUB>fh, </SUB>&#945;<SUB>n</SUB>) are  evaluated using Meites Israel and Gaur Bharagav<SUP>,</SUP>s method. Further,  with increase in temperature the values of K<SUP>0</SUP><SUB>fh </SUB>also  increase, showing that irreversibility of the system decreases on increasing the  temperature.</P>     ]]></body>
<body><![CDATA[<P ><B>Keywords</B>: DC polarography, reduction, antidepressant drug, Bupropion    hydrochloride.</P>     <P >&nbsp;</P>     <P ><B>Introduction</B></P>     <P >Bupropion (previously known as amfebutamone) is a typical antidepressant that    acts as a norepinephrine and dopamine reuptake inhibitor and nicotine antagonist.    It belongs to the chemical class of aminoketone and is similar in structure    to the stimulant cathionone, to the anorectic diethylpropion, and to the phenethylamines    in general. Initially researched and marketed as an antidepressant, Bupropion    was subsequently found to be effective as a smoking cessation aid [<a name="top1"></a><a href="#1">1</a>].  </P>     <P >Bupropion was the first non-nicotine based therapy for smoking cessation to    be approved by the Food and Drug Administration (FDA) and is still the most    widely prescribed [<a name="top2"></a><a href="#2">2</a>]. Interest in    Bupropion as a smoking cessation aid began after reports of successful cessation    by smokers prescribed the drug as antidepressant. However, Bupropion does not    appear to work via its antidepressant effects, i.e., it is effective in those    with or without current or past depressive symptoms [<a name="top3"></a><a href="#3">3-5</a>].  </P>     <P >Animal studies have shown that Bupropion has an effect on numerous nicotine    actions. It also alters brain reward circuits influenced by nicotine, reversing    the elevated intracranial self-stimulation thresholds resulting from nicotine    abstinence, thus impairing the negative reinforcing effects of nicotine [<a name="top6"></a><a href="#6">6-8</a>].</P>     <P >Although Bupropion<SUP>&#8217;</SUP>s mechanism of action is uncertain, it    appears to act on a number of brain pathways involved in dependence[<a name="top9"></a><a href="#9">9</a>].    It is known to inhibit the neuronal reuptake of dopamine in the mesolimbic system,    the pathway implicated in the reinforcing effects of nicotine and noradrenaline    in the locus coeruleus, which is thought to be involved in nicotine withdrawal.    Bupropion also acts as an antagonist for neuronal nicotinic acetylcholine receptors    [<a name="top10"></a><a href="#10">10-13</a>].</P>       <P >Bupropion has      formula weight 239.74 g/mol and melting point 233-234 <SUP>o</SUP>C. The hydrochloric      salt of Bupropion is a white crystalline powder with a bitter taste; freely      soluble in water, methanol, ethanol.</P>        <P >&nbsp;</P>     <P > <img src="/img/revistas/pea/v28n2/28n2a02e2.jpg" width="229" height="147">  </P>     
]]></body>
<body><![CDATA[<P >2-(tert-butylamino)-1-(3-chlorophenyl) propan-1-one</P>     <P >&nbsp;</P>     <P >Various methods have been reported for the estimation of Bupropion in pharmaceutical    preparations and biological fluids viz LC<SUP>14</SUP>, HPLC [<a name="top15"></a><a href="#15">15-16</a>]    and mass spectrometry [<a name="top17"></a><a href="#17">17</a>]. Although    chromatographic methods offer high degree of specificity, yet, sample clean    up and instrument limitations preclude their use in routine clinical studies.    Voltammetric technique offers another possibility for the estimation of this    compound. Review of the literature revealed that, up to the present time, nothing    has been reported concerning the polarographic behavior of Bupropion. The molecular    structure of the studied compound is characterized by the presence of an electroactive    reducible carbonyl group; this initiated the present study. The aim of the present    paper is to study the electrochemical behavior of Bupropion hydrochloride at    dropping mercury electrode by direct current polarography.</P>     <P >&nbsp;</P>     <P ><B>Experimental </B></P>     <P ><B  ><I  >Materials and reagents<U>  </U></I></B></P>     <P >A stock solution  of Bupropion hydrochloride (5´10<SUP>-3</SUP>) was prepared in triple distilled water and further  diluted with the same solvent to give appropriate concentration for the working  range. KNO<SUB>3 </SUB>(0.5 M), acetate buffer (0.1 M), B. R. buffer (0.04 M),  ammonium citrate buffer (0.2 M) were used as the supporting electrolytes.&nbsp; pH study was carried out in B. R. buffer  in the&nbsp; pH range 3.13- 11.0. All  solutions were prepared from Analar-grade reagents (Merck and Sigma) in triply  distilled water.</P>     <P >&nbsp;</P>     <P ><B  ><I  >Apparatus </I></B></P>     <P >Polarographic  experiments were carried out with Elico D.C. recording polarography CL 357. The  current voltage measurements were performed with three electrode assembly, a  dropping mercury electrode as working electrode, calomel as reference electrode  and platinum electrode as counter electrode. The current responses and applied  potentials were recorded at scan rate 100 mV/min. </P>     ]]></body>
<body><![CDATA[<P >The dropping  mercury electrode had the capillary characteristics, m = 2.768 mg/s, t = 3.0 s,  h = 60 cm. pH was adjusted to suitable range by Elico digital pH  meter.</P>     <P >&nbsp;</P>     <P ><B>Results and discussion</B></P>     <P >Electrochemical behavior of Bupropion hydrochloride has been studied in different    supporting electrolytes in aqueous medium. Reduction of carbonyl group in this    media gave one well-defined wave as expected. The reduction was found to be    diffusion controlled (the plot of id versus concentration was found to be linear    and also the temperature coefficient was found to be 1-2%/deg). </P>     <P >Linear plots  were obtained for log i/id-i versus E<SUB>d.e. </SUB>with slope  0.0591/&#945;<SUB>n</SUB> Volts and zero intercept on y-axis gave the value of  E<SUB>1/2</SUB>. The values of slopes indicated that the reduction of Bupropion  hydrochloride is irreversible. The kinetic parameters were calculated from  Meites-Israel method and also by the further modified Gaur-Bhargava<SUP>&#8217;</SUP>s  method.</P>     <P >According to  them the equation for irreversible wave was found to be</P>     <P >d.e.</SUB> = 0.05915/&#945;<SUB>n</SUB>log 1.349K<SUP>o</SUP><SUB>fh</SUB>t<SUP>1/2</SUP>/D<SUP>1/2</SUP> &#8211;  0.0542/&#945;<SUB>n</SUB>log i/id-i</P>     <P >which may be  written as</P>     <P >E<SUB>d.e. </SUB>= E<SUB>1/2</SUB>  &#8211; 0.0542/&#945;<SUB>n</SUB>log i/id-i</P>     <P >E<SUB>1/2</SUB> = 0.05915/&#945;<SUB>n</SUB> log  1.349K<SUP>o</SUP><SUB>fh</SUB>t<SUP>1/2</SUP>/D<SUP>1/2</SUP></P>     ]]></body>
<body><![CDATA[<P >where K<SUP>o</SUP><SUB>fh</SUB> = formal rate constant for forward reaction;    D = diffusion constant; &#945;<SUB>n</SUB> = transfer coefficient; and other    terms have usual significance.</P>     <P >Thus the value of &#945;<SUB>n</SUB> was obtained from the slope of the straight    line corresponding to E<SUB>d.e. </SUB>V/s log i/id-i. The intercept of the    same plot gives the value of E<SUB>1/2 </SUB>which was used to calculate K<SUP>o</SUP><SUB>fh</SUB>    after getting the value of D<SUP>1/2</SUP> from the Ilkovic equation. Meites    Israel has extended the Koutecky<SUP>&#8217;</SUP>s graphical method into comparatively    more precise mathematical form. Further, Gaur-Bhargava<SUP> </SUP>has also extended    the Koutecky<SUP>&#8217;</SUP>s treatment for irreversible wave, since according    to them the diffusion to the electrode surface (mercury drop) is spherical and    not a linear one, as assumed by Meites and Israel [<a name="top18"></a><a href="#18">18</a>].  </P>     <P >Gaur  Bhargava<SUP>&#8217;</SUP>s modification:-</P>     <P >E<SUB>1/2</SUB> = 0.05915/  &#945;<SUB>n</SUB> log K<SUP>0</SUP><SUB>fh</SUB>t<SUP>1/2</SUP>/(antilog  c)D<SUP>1/2</SUP></P>     <P >&nbsp;</P>     <P ><B  ><I  >Polarogram of Bupropion  hydrochloride in different supporting electrolytes</I></B></P>       <P >Electrochemical behavior of Bupropion      hydrochloride has been studied as a function of salt concentration in different      supporting electrolytes, as shown in Fig. 1:</P>       <p>&nbsp;</p>    <P ><img src="/img/revistas/pea/v28n2/28n2a02f1.jpg" width="323" height="264"></P>     
<P ><B  >Figure 1</B>. Current-voltage curves of Bupropion hydrochloride in various  supporting electrolytes- B, C, D and E were in B. R. buffer (0.04 M), acetate  buffer (0.1 M), ammonium citrate buffer (0.2 M), KNO<SUB>3 </SUB>(0.5 M),  respectively.</P>     ]]></body>
<body><![CDATA[<P >&nbsp;</P>     <P >From the graphs it is clear that the diffusion currents decrease with the    increase in concentration of the salt. Since the diffusion current i<SUB>d</SUB>    depends on the diffusion coefficient of the electroactive species, which in    turn depends on the viscosity of the solution, increasing the viscosity causes    i<SUB>d </SUB>to decrease [<a name="top19"></a><a href="#19">19</a>].</P>     <P >Further, the half wave potential of the drug shifts to the more negative direction    on increasing the concentration of the salt and it was found to be 0.865, 0.925,    1.105, 1.170 Volts in B. R. buffer (0.04 M), acetate buffer (0.1 M), ammonium    citrate buffer (0.2 M), and KNO<SUB>3 </SUB>(0.5 M),&nbsp; respectively. This    increase in potential is due to the alteration in the rate of electron transfer    step for an irreversible electrode reaction [<a name="top20"></a><a href="#20">20</a>].</P>     <P >&nbsp;</P>     <P ><B  ><I>Effect</I><I  > of concentration  </I></B></P>     <P >Polarograms were  run of solutions containing Bupropion hydrochloride in concentrations ranging  from 5´10<SUP>-4 </SUP>M to 10<SUP>-3</SUP> in acetate buffer (pH=4.5) and  B. R. buffer (pH=2.87).</P>     <P >The results  indicate that the reaction is irreversible. The half-wave potential shifts  towards more negative value with increasing the concentration. This behavior was  observed in both buffers. Further, the height of the wave was found to vary  directly with the concentration indicating the electrode reaction to be  diffusion controlled. The values of K<SUP>0</SUP><SUB>fh</SUB> indicate that the  electrode reaction is more irreversible at low concentrations. The results are  shown in Table 1.</P>     <P >&nbsp;</P>     <P ><B >Table 1</B>. Effect of concentration.</P>     <P ><img src="/img/revistas/pea/v28n2/28n2a02t1.jpg" width="668" height="206"></P>     
]]></body>
<body><![CDATA[<P >&nbsp;</P>      <P ><B  ><I  >Effect of pH </I></B></P>     <P >Bupropion hydrochloride was found to be reduced at dme in the pH range 3.13-11.0    in B. R. buffer. Variation of half wave potential and diffusion current with    pH shows the involvement of proton in the electrode reaction [<a name="top21"></a><a href="#21">21</a>].    As the pH of the solution increases, the wave height increases up to pH 6.57,    than its height begins to decrease. In highly alkaline solution an ill defined    wave was observed which suggests that the drug was best reduced in slightly    acidic medium.</P>     <P >The half wave  potential shift to more negative direction on increasing the pH, showing that  the reduction becomes difficult at higher pH. Linear plots were obtained for log  i/i<SUB>d</SUB>-i versus E<SUB>d.e.</SUB> at every pH value. Assuming that the  rate-determining step involves the transfer of two electrons, the value of the  slope denotes that the reduction process is irreversible. From the values of  K<SUP>0</SUP><SUB>fh,</SUB> listed in Table 2, it is clear that the degree of  irreversibility increases as the pH value increases up to pH 7, after which it  decreases again. </P>     <P class=MsoNormal>&nbsp;</P>     <P ><B >Table 2</B>.&nbsp; Effect of pH.</P>     <P ><img src="/img/revistas/pea/v28n2/28n2a02t2.jpg" width="646" height="223"></P>     
<P >&nbsp;</P>      <P >The number of protons, involved in the reduction process for each pH value    was determined using the relation [<a name="top22"></a><a href="#22">22-23</a></sup>]:<SUP></SUP></P>     <P >&#916;E<SUB>1/2</SUB>/&#916;pH =  0.05915/&#945;<SUB>n</SUB>(Z<SUB>H</SUB><SUP>+</SUP>)</P>     ]]></body>
<body><![CDATA[<P >where  &#945;<SUB>n</SUB> is the transfer coefficient. The value of &#945;<SUB>n </SUB>is  calculated from the following equation </P>     <P >E = E<SUB>1/2 </SUB>&#8211;  (0.05915/ &#945;<SUB>n</SUB>) log  i/i<SUB>d</SUB>-i</P>     <P >where  i<SUB>d</SUB> is the diffusion current.</P>     <P >The Z<SUB>H</SUB><SUP>+</SUP> was found in between 0.18 to 0.41 at different    pH values, i.e., one proton is probably consumed in the rate-determining step    of the electrode reaction. This is further confirmed by the plot of E<SUB>1/2</SUB>    = f(pH); slope value is more nearly consistent with&nbsp; one proton involvement    (-30 to -60 mV/pH) than two (-60 to -120 mV/pH) [<a name="top24"></a><a href="#24">24</a><a href="#24"></a>].  </P>     <P ><img src="/img/revistas/pea/v28n2/28n2a02e3.jpg" width="229" height="21"></P>     
<P >&nbsp;</P>     <P ><B  ><I  >Effect of temperature </I></B></P>     <P >Titled drug exhibits single well defined reduction wave at all the temperatures    ranging from 15 <SUP>o</SUP>C to 35 <SUP>o</SUP>C. Temperature dependence on    the diffusion current for the reduction wave was found to be linear. The temperature    coefficient of the diffusion current, 1% to 4% per degree, is precisely that    to be associated with diffusion controlled process. Since the temperature coefficients    of the diffusion currents of most organic molecules are usually of the order    1% to 2%/deg [<a name="top25"></a><a href="#25">25</a>].&nbsp; The temperature    coefficients of the half wave potentials were 15-10 mV per degree, indicating    the irreversible electrode reaction [<a name="top26"></a><a href="#26">26</a>].    The results are shown in Table 3.</P>     <P >&nbsp;</P>     <P ><B >Table 3</B>. Effect of temperature.</P>     ]]></body>
<body><![CDATA[<P ><img src="/img/revistas/pea/v28n2/28n2a02t3.jpg" width="645" height="167"></P>      
<P >&nbsp;</P>     <P ><B>Conclusion</B></P>     <P >A simple and  sensitive method was developed for the qualitative determination of Bupropion  hydrochloride. The wave given by the titled drug was found to be diffusion  controlled since its height is proportional to concentration, varies with  concentration and nature of the supporting electrolyte, and its temperature  coefficient was found to be 1-2%/deg.</P>     <P >The behavior of  the half wave potential shows that the reaction is irreversible. While the half  wave potential is pH dependent, as one would expect for an organic reaction, the  shift per pH unit exceeds the theoretical values predicted for reversible  reactions. In addition, the half wave potential is not independent of  concentration, but apparently varies with its logarithmic value. pH study  reveals that drug can be best reduced in slightly acidic medium. Further, the  values of K<SUP>0</SUP><SUB>fh</SUB> increase with increase in temperature,  which suggests that irreversibility of the system decreases with increase in  temperature; this implies that the reduction product of the drug is stable at  lower temperature. Provided that proper attention is given to the factors of pH,  concentration, temperature, etc., on the half-wave potential, the wave could be  of value for qualitative identification.  <I></I></P>     <P >&nbsp;</P>     <P ><B>References</B></P>     <P ><a href="#top1">1</a><a name="1"></a>. M. Siepmann, K. Werner, C. Schindler,    R. Oertel, W. Kirch, <I>Psychopharmacology</I> 182 (2005) 597-598. [10.1007/s00213-005-0128-y]</P>     <P ><a href="#top2">2</a><a name="2"></a>. V.C. Wing, M. Shoaib, <I>Psychopharmacology</I>    195 (2007) 303-313. 10.1007/s00213-007-0902-0</P>     <P ><a href="#top3">3</a><a name="3"></a>. R.D. Hurt, D.P. Sachs, E.D. Glover,    K.P. Offord, J.A. Johnston, L.C. Dale, M.A. Khayrallah, D.R. Schroeder, P.N.    Glover, C.R. Sullivan, I.T. Croghan, P.M. Sullivan, <I  >&nbsp;N. Engl. J. Med. </I>337<I  > </I>(1997)<B  ><I > </I></B>1195-1202.</P>     ]]></body>
<body><![CDATA[<P ><a href="#top3">4</a>. M.G. Goldstein, <I>J. Clin. Psychiatry</I> 4 (1998)    66-72.</P>     <P ><a href="#top3">5</a>. K.E. Hayford, C.A. Patten, T.A. Rummans, D.R. Schroeder,    K.P. Offord, I.T. Crogham, E.D. Glover, D.P. Sachs, R.D. Hurt, <I >Br. J. Psychiatry    </I>174 (1999) 173-178.</P>     <P ><a href="#top6">6</a><a name="6"></a>. J.F. Cryan, A.W. Bruijnzeel, K.L. Skjei,    A. Markou, <I  >Psychopharmacology</I> 168 (2003) 347-358. [10.1007/s00213-003-1445-7]</P>     <P ><a href="#top6">7</a>. M.P. Epping-Jordan, S.S. Watkins, G.F. Koob, A. Markou,    <I  >Nature </I>393 (1998) 76-79. [10.1038/30001]</P>     <P ><a href="#top6">8</a>. J.E. Slemmer, B.R. Martin, M.I. Damaj, <I >J. Pharmacol.    Exp. Ther. </I>295<I  > </I>(2000) 321-327. </P>     <P ><a href="#top9">9</a><a name="9"></a>. C. Warner, M. Shoaib, <I >Addict. Biol</I>.    10 (2005) 219-231. [10.1080/13556210500222670]</P>     <P ><a href="#top10">10</a><a name="10"></a>. J.A. Ascher, J.O. Cole, L.N. Colin,    J.P. Feighner, R.M. Ferris, H.C. Fibiger, R.N. Golden, P. Martin, W.Z. Potter,    E. Richelson et al., <I  >J. Clin. Psychiatry</I> 56 (1995) 395-401.</P>     <P ><a href="#top10">11</a>. W.A. Corrigal, K.B. Franklin, K.M. Coen, P.B. Clarke,    <I  >Psychopharmacology</I> 107 (1992) 285-289. [10.1007/BF02245149]</P>     <P ><a href="#top10">12</a>. R.M. Ferris, B.R. Cooper, R.A. Maxwell, <I  >J. Clin. Psychiatry</I> 4 (1983) 74-78.</P>     <P ><a href="#top10">13</a>. L.H. Ferry, <I >Prim. Care</I> 26 (1999) 653-69.</P>     ]]></body>
<body><![CDATA[<P >14.   R. Coles, E.D. Kharasch, <I>J. Chromatography B</I> 857 (2007) 67-75.  [10.1016/j.jchromb.2007.07.007]</P>     <P ><a href="#top15">15</a><a name="15"></a>. M. Qi, P. Wang, Y. Geng, J. Gu,    R. Fu, <I>J. Chinese Pharma. Sci. </I>11 (2002) 16-18.</P>     <P ><a href="#top15">16</a>. T.A. Jennison, P. Brown, J. Crossett, M.F. Urry,    <I>J. Analytical Toxicology</I> 19 (1995) 69-72.</P>     <P ><a href="#top17">17</a><a name="17"></a>. F. Badoud, E. Grata, L. Perrenoud,    L. Avois, M. Saugy, S. Rudag, J.L. Veuthey, <I>J. Chromatography, A</I> 1216    (2009) 4423-4433. [10.1016/j.chroma.2009.03.033]</P>     <P ><a href="#top18">18</a><a name="18"></a>. L. Meites, Y. Isral, <I >J. Am.    Chem. Soc.</I> 83 (1961) 4903-4906. [10.1021/ja01485a008]</P>     <P ><a href="#top19">19</a><a name="19"></a>. L. Meites, <I >Polarographic techniques</I>,    Brooklyn, New York, 1964,<B  > </B>p.141.</P>     <P ><a href="#top20">20</a><a name="20"></a>. L. Meites, <I >Polarographic techniques</I>,    Brooklyn, New York, 1964, p.291.</P>     <P ><a href="#top21">21</a><a name="21"></a>. N.T. Abdel Ghani, M.A. El-Ries,    M.A. EL-Shall, <I >Anal. Sci. </I>23 (2007) 1053-1058. [10.2116/analsci.23.1053]</P>     <P ><a href="#top22">22</a><a name="22"></a>. A.A. AI-Majed, F. Belal, A. Abadi,    A.M.-Al-obaid, <I>Il</I> <I >Farmaco</I> 55<B  > </B>(2000) 233-238. [10.1016/S0014-827X(00)00009-4]</P>     <!-- ref --><P ><a href="#top22">23</a>. N. El-Enany, A. Ei-Brashy, F. Belal, N. El-Bahay,    <I  >Port. Electrochim. Acta </I>27 (2009)<B  > </B>113-125. [10.4152/pea.200902113]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000112&pid=S0872-1904201000020000200001&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><P ><a href="#top24">24</a><a name="24"></a>. P. Zuman, <I >J. Solid State Electrochem.</I>    10 (2006) 841-851. [10.1007/s10008-006-0177-0]</P>     <P ><a href="#top25">25</a><a name="25"></a>. L. Meites, <I >Polarographic techniques</I>,    Brooklyn, New York, 1964, p.139-140.</P>     <P ><a href="#top26">26</a><a name="26"></a>. L. Meites, <I >Polarographic techniques</I>,    Brooklyn, New York, 1964, p.288.</P>     <P >&nbsp;</P>     <P >Received 29 July 2009; accepted 10 May 2010</P>     <P >&nbsp;</P>     <P ><a name="c1"></a><a href="#topc1">*</a> Corresponding author: <a href="mailto:sharda033@yahoo.com">sharda033@yahoo.com</a></P>     <P >&nbsp;</P>     ]]></body><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[El-Enany]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Ei-Brashy]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Belal]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[El-Bahay]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
</person-group>
<source><![CDATA[Port. Electrochim. Acta]]></source>
<year>2009</year>
<volume>27</volume>
<page-range>113-125</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
